Clinical Trial Update: Safety and Efficacy Study of MM-093 in Patients With Chronic Plaque Psoriasis [Phase 2]

View source ↗

Summary

Phase 2 safety and efficacy study of MM-093 in chronic plaque psoriasis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• MM-093 (MM-093)

Snippet

Sponsor: Merrimack Pharmaceuticals | Conditions: Psoriasis | Phase 2 | Status: COMPLETED